secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001104659-24-007993
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel terminates CMO Mark Kirschbaum; appoints board member Brian Schwartz as interim CMO
--------------------------------------------------------------------------------

- Employment of Mark H. Kirschbaum, M.D. as Chief Medical Officer terminated effective January 25, 2024; no severance benefits.
- Dr. Brian Schwartz, a board member, appointed interim CMO effective immediately; will not be independent while serving.
- Kirschbaum eligible for COBRA health continuation; other benefits end January 31, 2024 if not elected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924007993/0001104659-24-007993-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924007993/tm244458d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-007993

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer